REFERENCES
- Hardy HL, Tabershaw IR: Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J Indust Hyg Toxicol. 1946;28:197–211.
- Sterner JH, Eisenbud M: Epidemiology of beryllium intoxication. AMA Arch Ind Hyg Occup Med. 1951;4:123–151.
- Eisenbud M: The standard for control of chronic beryllium disease. Appl Occup Environ Hyg. 1998;13:25–31. [CSA]
- Kreiss K, Mroz MM, Newman LS, Martyny J, Zhen B: Machining risk of beryllium disease and sensitization with median exposures below 2 µg/m3. Am J Ind Med. 1996;30:16–25. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kreiss K, Mroz MM, Zhen BG, Wiedemann H, Barna B: Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med. 1997;54:605–612. [PUBMED], [INFOTRIEVE], [CSA]
- Newman LS, Lloyd J, Daniloff E: The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect. 1996;104((Suppl 5)):937–943. [PUBMED], [INFOTRIEVE]
- Newman LS, Kreiss K, King TE, Seay S, Campbell PA: Pathologic and immunologic alterations in early stages of beryllium disease: re-examination of disease definition and natural history. Am Rev Respir Dis. 1989;139:1479–1486. [PUBMED], [INFOTRIEVE], [CSA]
- Saltini C, Amicosante M: Beryllium disease. Am J Med Sci. 2001;321:89–98. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tinkle SS, Antonini JM, Rich BA, Roberts JR, Salmen R, DePree K, Adkins EJ: Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect. 2003;111:1202–1208. [PUBMED], [INFOTRIEVE], [CSA]
- Eidson AF, Taya A, Finch GL, Hoover MD, Cook C: Dosimetry of beryllium in cultured canine pulmonary alveolar macrophages. J Toxicol Environ Health. 1991;34:433–448. [PUBMED], [INFOTRIEVE]
- Richeldi L, Sorrentino R, Saltini C: HLA-DPß1 glutamate 69: a genetic marker of beryllium disease. Science. 1993;262:242–244. [PUBMED], [INFOTRIEVE]
- Day GA: In Vitro Transformation of Phagocytized Beryllium Oxide Particles in the Murine J774A.1 Cell [PhD dissertation]. Oklahoma City, OK: University of Oklahoma Health Sciences Center; 2002.
- Hoover MD, Castorina BT, Finch GL, Rothenberg SJ: Determination of the oxide layer thickness on beryllium metal particles. Am Ind Hyg Assoc J. 1989;50:550–553. [PUBMED], [INFOTRIEVE], [CSA]
- ICRP. International Commission on Radiological Protection: Human Respiratory Tract Model for Radiological Protection. ICRP Publication 66. Oxford: Pergamon Press; 1994.
- Stefaniak AB, Hoover MD, Dickerson RM, Peterson EJ, Day GA, Breysse PN, Kent MS, Scripsick RC: Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease. Am Ind Hyg Assoc J. 2003;64:297–305. [CSA]
- Stefaniak AB, Guilmette RA, Day GA, Hoover MD, Breysse PN, Scripsick RC: Characterization of phagolysosomal stimulant fluid for study of beryllium aerosol dissolution. Toxicol In Vitro. 2005;19:123–134. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Stefaniak AB, Hoover MD, Day GA, Dickerson RM, Peterson EJ, Kent MS, Schuler CR, Breysse PN, Scripsick RC: Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit. 2004;6:523–532. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Butnor KJ, Sporn TA, Ingram P, Gunasegaram S, Pinto JF, Roggli VL: Beryllium detection in human lung tissue using electron probe x-ray microanalysis. Mod Pathol. 2003;16:1171–1177. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fletcher RA, Small JA: Analysis of individual collected particles. In: Willeke K, Baron PA, eds. Aerosol Measurement: Principles, Techniques, and Applications. New York: Wiley; 1993:260–295.
- Pearson WB, Villars P, Calvert LD: Pearson's Handbook of Crystallographic Data for Intermetallic Phases, 2nd ed. Metals Park, OH: ASM International; 1991.
- Pratsinis SE, Kodas TT: Manufacturing of materials by aerosol processes. In: Willeke K, Baron PA, eds. Aerosol Measurement: Principles, Techniques, and Applications. New York: Wiley; 1993:721–746.
- Larson AC, Von Dreele RB: General Structure Analysis System (GSAS). Los Alamos National Laboratory Technical Report LA-UR 86-748(Rev. 9/2/94); 1985–1994.
- Toby BH: EXPGUI, a graphical user interface for GSAS. J Appl Cryst. 2001;34:210–213. [CROSSREF]
- Appel BR: Atmospheric sample analysis and sampling artifacts. In: Willeke K, Baron PA, eds. Aerosol Measurement: Principles, Techniques, and Applications. New York: Wiley; 1993:233–259.
- Heuser J: Changes in lysosome shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol. 1989;108:855–864. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jahraus A, Tjelle T, Berg T, Habermann A, Storrie B, Ullrich O, Griffiths G: In vitro fusion of phagosomes with different endocytic organelles from J774 macrophages. J Biol Chem. 1998;273:30379–30390. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Snyderman R, Pike MC, Fischer DG, Koren JS: Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. J Immunol. 1977;119:2060–2066. [PUBMED], [INFOTRIEVE]
- Ralph P, Nakoinz I: Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature. 1975;257:393–394. [PUBMED], [INFOTRIEVE]
- Ji J, Rosenzweig N, Griffin C, Rosenzweig Z: Synthesis and application of submicrometer fluorescence sensing particles for lysosomal pH measurements in murine macrophages. Anal Chem. 2000;72:3497–3503. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Möller W, Kreyling WG, Kohlhäufl M, Häussinger K, Heyder J: Macrophage functions measured by magnetic microparticles in vivo and in vitro. J Magn Magn Mater. 2001;225:218–225. [CSA], [CROSSREF]
- Takenaka S, Karg E, Möller W, Roth C, Ziesenis A: A morphologic study on the fate of ultrafine silver particles: distribution pattern of phagocytized metallic silver in vitro and in vivo. Inhal Toxicol. 2000;12((Suppl 3)):291–299.
- Finch GL, Verburg RJ, Mewhinney JA, Eidson AF, Hoover MD.: The effect of beryllium compound solubility on in vitro canine alveolar macrophage cytoxicity. Toxicol Lett. 1988;41:97–105. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Finch GL, Lowther WT, Hoover MD, Brooks AL: Effects of beryllium metal particles on the viability and function of cultured rat alveolar macrophages. J Toxicol Environ Health. 1991;34:103–114. [PUBMED], [INFOTRIEVE]
- Hinds WC: Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles, 2nd ed. New York: Wiley; 1999.
- Mercer TT: On the role of particle size in the dissolution of lung burdens. Health Phys. 1967;13:1211–1221. [PUBMED], [INFOTRIEVE]
- Lehnert BE, Morrow PE: Association of 59iron oxide with alveolar macrophages during alveolar clearance. Exp Lung Res. 1985;9:1–16. [PUBMED], [INFOTRIEVE], [CSA]
- Sanders CL: The distribution of inhaled plutonium-239 dioxide particles within pulmonary macrophages. Arch Environ Health. 1969;18:904–912. [PUBMED], [INFOTRIEVE]
- Guilmette RA: Issues and research on the biochemistry of inhaled actinides. J Alloy Compd. 1998;271:66–71. [CROSSREF]
- Heilmann P, Beisker W, Miaskowski U, Camner P, Kreyling WG: Intraphagolysosomal pH in canine and rat alveolar macrophages: flow cytometric measurements. Environ Health Perspect. 1992;97:115–120. [PUBMED], [INFOTRIEVE]
- Nessa K, Palmberg L, Johard U, Malmberg P, Jarstrand C, Camner P: Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. Environ Res. 1997;75:141–148. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nyberg K, Johansson A, Camner P, Johard U, Eklund A: Phagolysosomal pH in alveolar macrophages from smokers and nonsmokers. Hum Exp Toxicol. 1994;13:175–179. [PUBMED], [INFOTRIEVE], [CSA]
- Kanapilly GM: Alveolar microenvironment and its relationship to the retention and transport into blood of aerosols deposited in the alveoli. Health Phys. 1977;32:89–100. [PUBMED], [INFOTRIEVE]
- Kreyling WG: Intracellular particle dissolution in alveolar macrophages. Environ Health Perspect. 1992;97:121–126. [PUBMED], [INFOTRIEVE]
- Lundborg M, Lind B: Camner P: Ability of rabbit alveolar macrophages to dissolve metals. Exp Lung Res. 1984;7:11–22. [PUBMED], [INFOTRIEVE]
- Lundborg M, Eklund A, Lind B: Camner P: Dissolution of metals by human and rabbit alveolar macrophages. Br J Ind Med. 1985;42:642–645. [PUBMED], [INFOTRIEVE]
- Kreyling WG, Neuner M, Matejkova E: Analysis of intraphagolysosomal dissolution of test particles in canine alveolar macrophages. J Aerosol Sci. 1988;19:1071–1074. [CSA], [CROSSREF]
- Kreyling WG, Godleski JJ, Kariya ST, Rose RM, Brain JD: In vitro dissolution of uniform cobalt oxide particles by human and canine alveolar macrophages. Am J Respir Cell Mol Biol. 1990;2:413–422. [PUBMED], [INFOTRIEVE]
- Marafante E, Lundborg M, Vahter M, Camner P: Dissolution of two arsenic compounds by rabbit alveolar macrophages in vitro. Fundam Appl Toxicol. 1987;8:382–388. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- André S, Métivier H, Lantenois G, Boyer M, Nolibé D, Masse R: Beryllium metal solubility in the lung, comparison of metal and hot-pressed forms by in vivo and in vitro dissolution bioassays. Hum Toxicol. 1987;6:233–240. [CSA]
- Finch GL, Mewhinney JA, Hoover MD, Eidson AF, Haley PJ, Bice DE: Clearance, translocation, and excretion of beryllium following acute inhalation of beryllium oxide by beagle dogs. Fundam Appl Toxicol. 1990;15:231–241. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Finch GL, Mewhinney JA, Eidson AF, Hoover MD, Rothenberg SJ: In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J Aerosol Sci. 1988;19:333–342. [CSA], [CROSSREF]
- Stefaniak AB: Influence of Physicochemical Properties on Dissolution of Beryllium from Respirable Beryllium Particles and Powders Associated with Prevalence of Chronic Beryllium Disease [PhD Dissertation]. Baltimore, MD: Johns Hopkins University Bloomberg School of Public Health; 2004.
- Hanifin JM, Epstein WL, Cline MJ: In vitro studies of granulomatous hypersensitivity to beryllium. J Invest Dermatol. 1970;55:284–288. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Deodhar SD, Barna BP: Van Ordstrand HS: A study of the immunologic aspects of chronic berylliosis. Chest. 1973;63:309–313. [PUBMED], [INFOTRIEVE]
- Jones JM: Amos HE: Antigen formation in metal contact sensitivity. Nature. 1975;256:499–500. [PUBMED], [INFOTRIEVE]
- Hart BA, Pittman DG: The uptake of beryllium by the alveolar macrophage. J Reticuloendothel Soc. 1980;27:49–58. [PUBMED], [INFOTRIEVE]
- Witschi HP, Aldridge WN: Uptake, distribution, and binding of beryllium to organelles of the rat liver cell. Biochem J. 1968;106:811–820. [PUBMED], [INFOTRIEVE]
- Haley PJ: Mechanisms of granulomatous lung disease from inhaled beryllium: the role of antigenicity in granuloma formation. Toxicol Pathol. 1991;19:514–525. [PUBMED], [INFOTRIEVE]
- Haley PJ, Finch GL, Mewhinney JA, Harmsen AG, Hahn FF, Hoover MD, Muggenburg BA, Bice DE: A canine model of beryllium-induced granulomatous lung disease. Lab Invest. 1989;61:219–227. [PUBMED], [INFOTRIEVE], [CSA]
- Haley PJ, Finch GL, Mewhinney JA, Hoover MD, Muggenburg BA, Bice DE: Beryllium-induced lung disease in the dog following repeated BeO exposure. In: Annual Report of the Inhalation Toxicology Research Institute, LMF-126. Albuquerque, NM; 1989
- Jones Williams W, Wallach ER: Laser probe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis and other granulomatous diseases. Sarcoidosis. 1989;6:111–117.
- Epstein PE, Dauber JH, Rossman MD, Daniele RP: Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis. Ann Intern Med. 1982;97:213–216. [PUBMED], [INFOTRIEVE]
- Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG: Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med. 1989;320:1103–1109. [PUBMED], [INFOTRIEVE]
- Fontenot AP, Kotzin BL, Comment CE, Newman LS: Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Am J Respir Cell Mol Biol. 1998;18:581–589. [PUBMED], [INFOTRIEVE], [CSA]
- Fontenot AP, Falta MT, Freed BM, Newman LS: Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol. 1999;163:1019–1026. [PUBMED], [INFOTRIEVE]
- Sawyer RT, Maier LA, Kittle LA, Newman LS: Chronic beryllium disease: a model interaction between innate and acquired immunity. Int Immunopharmacol. 2002;2:249–261. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL: Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A. 2000;97:12717–12722. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sinigaglia F: The molecular basis of metal recognition by T-cells. J Invest Dermatol. 1994;102:398–401. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Scott BL, Wang Z, Marrone BL, Sauer NN: Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study. J Inorg Biochem. 2003;94:5–13. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tinkle SS, Schwitters PW, Newman LS: Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease. Environ Health Perspect. 1996;104(Suppl 5):969–971. [PUBMED], [INFOTRIEVE]
- Tinkle SS, Kittle LA, Schumacker BA, Newman LS: Beryllium induces IL-2 and IFN-gamma in berylliosis. J Immunol. 1997;158:518–526. [PUBMED], [INFOTRIEVE]
- Tinkle SS, Newman LS: Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am J Respir Crit Care Med. 1997;156:1884–1891. [PUBMED], [INFOTRIEVE], [CSA]
- Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL.: Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease. J Clin Invest. 2002;10:1473–1482. [CROSSREF]
- Fontenot AP, Newman LS, Kotzin BL: Short analytical review—chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Clin Immunol. 2001;100:4–14. [PUBMED], [INFOTRIEVE], [CROSSREF]